AIM’s Latest Newsletter: The Research Edition, July 2023
Published:
08/01/2023

This month’s newsletter focuses on the latest news and scientific breakthroughs in melanoma research.
This edition features:
- Letter from AIM’s President, Sam Guild
- Notes From the Lab: Novel Targets for Immune Checkpoint Inhibitors
By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory - In Plain English: Neoadjuvant Therapy for Melanoma, and How We Got Here
By Kim Margolin, M.D., FACP, FASCO - Clinical Trials Catch Up: An Interview with Joshua M.V. Mammen, M.D., Ph.D., F.A.C.S.
By Alicia Rowell, Vice President, AIM at Melanoma
Recent Posts

Jul. 01, 2025
The Cost of Sunscreen May Be Costing Lives

Jul. 01, 2025
A Conversation with Dr. Rena Szabo, PsyD on Empowering Patients

Jun. 18, 2025
Empowering Women in Melanoma: A Look Inside the Women in Melanoma Initiative

Jun. 18, 2025
Melanoma News and Highlights You Don’t Want to Miss

Jun. 10, 2025